TabsDetailsBasic DetailsDate: Wednesday, August 28, 2019Type: PresentationMedical Product: dolutegravirMaterials: Dolutegravir Use Among Women of Child-Bearing Potential and During Early Pregnancy Additional InformationInformationHost: 35th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementRelated Assessment(s): Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 2019Dolutegravir Use During PregnancyContributorsPresenter(s): James Phillip Trinidad, Talia Menzin, Elizabeth Dee, Monique Falconer, Mayura Shinde
